Cargando…
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
Cellular immunotherapy, including the chimeric antigen receptor T (CAR-T) cell therapy and CAR- natural killer (CAR-NK) cell therapy, has undergone extensive clinical investigation and development in recent years. CAR-T cell therapy is now emerging as a powerful cancer therapy with enormous potentia...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508791/ https://www.ncbi.nlm.nih.gov/pubmed/36153595 http://dx.doi.org/10.1186/s40164-022-00316-8 |